MLSS

Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within PRC Alliance Pain Relief Center in Ormond Beach, Florida

Retrieved on: 
Wednesday, April 3, 2024
Johns Hopkins Hospital, MLSS, Anesthesia, Risk, Trauma, MD, ESI, CPT, ASC, Injection, Safety, Spine, Pain management, Pain, Physician, Epidural steroid injection, Nursing

ROSELAND, N.J., April 03, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it has commenced sales of CompuFlo® Epidural disposables into PRC Alliance Pain Relief Center at Ormond Beach, Florida. PRC Alliance Pain Relief Centers operates 7offices and an ambulatory surgical center (ASC) located across Central Florida, with 15 providers. PRC Alliance Pain Relief Centers is a family of pain management specialists who are dedicated to relieving pain through exceptional and compassionate care.

Key Points: 
  • ROSELAND, N.J., April 03, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it has commenced sales of CompuFlo ® Epidural disposables into PRC Alliance Pain Relief Center at Ormond Beach, Florida.
  • PRC Alliance Pain Relief Centers operates 7offices and an ambulatory surgical center (ASC) located across Central Florida, with 15 providers.
  • PRC Alliance Pain Relief Centers is a family of pain management specialists who are dedicated to relieving pain through exceptional and compassionate care.
  • Adoption of the technology follows a successful evaluation by Dr. Sanjay Bakshi, MD, a pain management physician and CEO of PRC Alliance Pain Relief Centers in Ormond Beach, Florida.

Milestone Scientific Achieves 12% Increase in Revenue and 39% Increase in Gross Profit for the Year Ended 2023

Retrieved on: 
Monday, April 1, 2024
Growth, MLSS, Webcast, Telephone, Education, Dental Service Organizations, Operating cost, Hospital, United, CPT, Injection, Pain management, STA, Physician

Arjan Haverhals, CEO and President of Milestone Scientific, stated, “We achieved solid financial results in 2023, with revenue increasing 11.6% and gross profit increasing 39%.

Key Points: 
  • Arjan Haverhals, CEO and President of Milestone Scientific, stated, “We achieved solid financial results in 2023, with revenue increasing 11.6% and gross profit increasing 39%.
  • For the year ended December 31, 2023, international revenue was approximately $4.1 million, a decrease of $724,000 compared to December 31, 2022.
  • Gross profit for the year ended December 31, 2023, was $6.8 million versus $4.9 million for the year ended December 31, 2022.
  • Operating loss for the year ended December 31, 2023, was $7.1 million versus $8.8 million for the year ended December 31, 2022.

Milestone Scientific Schedules 2023 Year-End Financial Results and Business Update Conference Call

Retrieved on: 
Thursday, March 28, 2024
Webcast, Telephone, MLSS, Injection

ROSELAND, N.J., March 28, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Monday, April 1, 2024, to discuss the company’s financial results for 2023, as well as the company’s corporate progress and other developments

Key Points: 
  • ROSELAND, N.J., March 28, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Monday, April 1, 2024, to discuss the company’s financial results for 2023, as well as the company’s corporate progress and other developments
    The conference call will be available via telephone by dialing toll free 888-506-0062 for U.S. callers or +1 973-528-0011 for international callers and by entering the access code: 222156.
  • A webcast and replay of the call may be accessed at Webcast URL: https://www.webcaster4.com/Webcast/Page/2306/50281 .
  • An audio replay of the call will be available through April 15, 2024, and can be accessed by dialing 877-481-4010 for U.S. callers or +1 919-882-2331 for international callers and by entering the access code: 50281.

Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Omaha Pain Physicians

Retrieved on: 
Thursday, March 14, 2024
MLSS, Patient, University, Chronic pain, ESI, Neck pain, Injection, Safety, Spine, Pain management, Physician, Epidural steroid injection, Dentistry

ROSELAND, N.J., March 14, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it has commenced sales of CompuFlo ® Epidural disposables to Omaha Pain Physicians , a comprehensive medical pain management center in Omaha, NE.

Key Points: 
  • ROSELAND, N.J., March 14, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it has commenced sales of CompuFlo ® Epidural disposables to Omaha Pain Physicians , a comprehensive medical pain management center in Omaha, NE.
  • Omaha Pain Physicians is focused on treating patients with acute and chronic pain.
  • Dr. Matthew Stottle completed 10 cases using the CompuFlo Epidural system at Omaha Pain Physicians, in which he reported 100% success.
  • The evaluation included Epidural Steroid Injection (ESI) procedures within the lumbar, thoracic and cervical thoracic junction of the spine.

Milestone Scientific Commences Direct Sales of STA Single Tooth Anesthesia System® with Meridian Endo & Perio

Retrieved on: 
Wednesday, February 28, 2024
MLSS, Injection, Endodontics, Overalls, STA, Patient, Teaching, Periodontology, Dentistry

ROSELAND, N.J., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announces it has commenced direct sales of its STA Single Tooth Anesthesia System® (STA) with Meridian Endo & Perio , a large endodontics, periodontics and implant dentistry practice with three offices in Wisconsin.

Key Points: 
  • ROSELAND, N.J., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announces it has commenced direct sales of its STA Single Tooth Anesthesia System® (STA) with Meridian Endo & Perio , a large endodontics, periodontics and implant dentistry practice with three offices in Wisconsin.
  • Dr. Lisa Teel, periodontist and implant surgeon with Meridian Endo and Perio, stated, “Our practice is committed to adopting the latest technologies to improve the overall patient experience.
  • Upon introduction, we were struck by the ease of use, as well as the STA’s ability to put patients at ease with dental anesthesia.
  • Moreover, we appreciate the ongoing educational and training support provided by Milestone Scientific.”
    Arjan Haverhals, Chief Executive Officer of Milestone Scientific, commented, “This latest agreement illustrates the benefits of our new direct sales model.

Milestone Scientific Commences Direct Sales of STA Single Tooth Anesthesia System® to Maine Dental Group, a Premier Group Practice with 21 Locations Across the Northeast

Retrieved on: 
Tuesday, February 20, 2024
MLSS, Injection, American Dental Association, Dentist, Marketing, DSO, STA, Dental Service Organizations, Patient, Dentistry

ROSELAND, N.J., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announces it has commenced sales of its STA Single Tooth Anesthesia System® (STA) with Maine Dental Group , a premier group of 21 dental practices across the northeastern United States.

Key Points: 
  • ROSELAND, N.J., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announces it has commenced sales of its STA Single Tooth Anesthesia System® (STA) with Maine Dental Group , a premier group of 21 dental practices across the northeastern United States.
  • We are executing our new sales strategy, which allows us to leverage a lean sales organization, while providing a cost-effective means to scale the business.
  • According to the American Dental Association, approximately 23% of all dentists are now affiliated with group practices and DSOs.
  • We could not be more pleased with the STA, and plan on expanding its use within our group.”

Milestone Scientific CEO Provides Letter to Shareholders; Provides Positive Reimbursement Update

Retrieved on: 
Tuesday, January 16, 2024
Patient, Injection, Traction, Health, Medicare, UTMB, Standard of care, Pain management, University, Spine, CPT, FDA, Physician, Letter, Epidural space, Patient safety, Education, MLSS, Pharmaceutical industry

I am proud to report we are making steady progress in advancing commercialization of the CompuFlo technology.

Key Points: 
  • I am proud to report we are making steady progress in advancing commercialization of the CompuFlo technology.
  • Several advisory sites were established across the US that implemented the CompuFlo technology in their practice.
  • The medical decision by physicians to use CompuFlo demonstrates the clinical utility and benefit of the technology in patient care.
  • A review and analysis of claims data shared by providers indicated that roughly one-third of claims have already received positive payor reimbursement.

Milestone Scientific Inc. Announces Closing of $3.0 Million Public Offering of Common Stock

Retrieved on: 
Wednesday, December 13, 2023
Telephone, Sale, Form, Injection, Attention, S-3, Prospectus, Security (finance), MLSS, Offering

ROSELAND, N.J., Dec. 13, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the closing of its previously announced underwritten public offering of 4,765,000 shares of its common stock at a public offering price of $0.63 per share (the “Offering”).

Key Points: 
  • ROSELAND, N.J., Dec. 13, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the closing of its previously announced underwritten public offering of 4,765,000 shares of its common stock at a public offering price of $0.63 per share (the “Offering”).
  • Gross proceeds before deducting underwriting discounts, commissions and other Offering expenses were approximately $3.0 million.
  • The Company has granted the underwriter a 45-day option to purchase up to an additional 714,750 shares of common stock, on the same terms and conditions.
  • The shares of common stock were offered pursuant to a registration statement on Form S-3 (File No.

Milestone Scientific Commences Sales of CompuFlo®  Disposables for Use in Neurostimulation Spinal Cord Implantation Procedures

Retrieved on: 
Friday, December 8, 2023
Baylor University, MD Anderson Cancer Center, Baylor College of Medicine, Cleveland Clinic, Trauma, Risk, UTHealth School of Dentistry, American Epilepsy Society, Physician, Injection, Electricity, Spinal cord, Hospital, MD, UTMB, Congress, University, Chronic pain, Nursing, Safety, MLSS

ROSELAND, N.J., Dec. 08, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today reported it has commenced commercial sales of CompuFlo® disposables for use in neurostimulation spinal cord stimulator implantation procedures at the University of Texas Medical Branch (UTMB) Health Clear Lake Campus Hospital, expanding use of CompuFlo® within the institution beyond the labor and delivery department and training for residents in epidural needle placement and verification.

Key Points: 
  • A spinal cord stimulator is an implanted device that sends low levels of electricity directly into the spinal cord to relieve pain.
  • An estimated 60,000 spinal cord stimulators are implanted each year.
  • Approval and adoption of the technology for neurostimulation spinal cord stimulator implantation follows a successful evaluation process by Dr. Patrick Karas, MD, a full-time faculty neurosurgeon at UTMB, operating at both the Galveston and Clear Lake campuses.
  • Dr. Karas completed 10 cases using the CompuFlo Epidural system, in which he reported 100% success and no complications.

Milestone Announces Agreement with Bioline Supply to Distribute the CompuFlo® Epidural System and Related Disposables Across Spain

Retrieved on: 
Tuesday, November 28, 2023
Pain management, Risk, Physician, Pain, Injection, Bioline, Hospital, Spine, Anesthesiology, Patient, Safety, MLSS

ROSELAND, N.J., Nov. 28, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced it has entered into an agreement with Bioline Supply to distribute the CompuFlo® Epidural System and related disposables in Spain.

Key Points: 
  • ROSELAND, N.J., Nov. 28, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced it has entered into an agreement with Bioline Supply to distribute the CompuFlo® Epidural System and related disposables in Spain.
  • Bioline is a premier distributor of medical devices and equipment, supporting many hospitals and pain clinics across Spain.
  • In connection with the agreement, Milestone Scientific has commenced sales and shipments of its CompuFlo Epidural Instrument and consumables to Spain.
  • Giacomo Damiani, CEO of Bioline Supply, stated, “We are pleased to add the CompuFlo® Epidural System to our product portfolio.